Luca Malcovati

1999–2025 年に発表

141
論文数
30,798
被引用数
83
h 指数
129
i10 指数

被引用数

Luca Malcovati の年別被引用数1989 年: 被引用 2 件1996 年: 被引用 1 件2000 年: 被引用 3 件2004 年: 被引用 2 件2005 年: 被引用 3 件2006 年: 被引用 32 件2007 年: 被引用 45 件2008 年: 被引用 77 件2009 年: 被引用 79 件2010 年: 被引用 82 件2011 年: 被引用 88 件2012 年: 被引用 170 件2013 年: 被引用 207 件2014 年: 被引用 281 件2015 年: 被引用 284 件2016 年: 被引用 288 件2017 年: 被引用 241 件2018 年: 被引用 227 件2019 年: 被引用 799 件2020 年: 被引用 858 件2021 年: 被引用 899 件2022 年: 被引用 885 件2023 年: 被引用 861 件2024 年: 被引用 1,402 件2025 年: 被引用 590 件2026 年: 被引用 15 件1990〜1995 年は被引用が無いため表示していません1997〜1999 年は被引用が無いため表示していません2001〜2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,208 件、この内訳の 24.5%イタリア: 引用元論文 761 件、この内訳の 8.4%ドイツ: 引用元論文 743 件、この内訳の 8.2%イギリス: 引用元論文 659 件、この内訳の 7.3%フランス: 引用元論文 536 件、この内訳の 6%スペイン: 引用元論文 404 件、この内訳の 4.5%中国: 引用元論文 385 件、この内訳の 4.3%カナダ: 引用元論文 288 件、この内訳の 3.2%オランダ: 引用元論文 259 件、この内訳の 2.9%日本: 引用元論文 246 件、この内訳の 2.7%スウェーデン: 引用元論文 237 件、この内訳の 2.6%オーストラリア: 引用元論文 214 件、この内訳の 2.4%
0%24.5%その他 23%

分野

  • Medicine73.8%
  • Biochemistry, Genetics and Molecular Biology20.9%
  • Immunology and Microbiology3.8%
  • Computer Science0.6%
  • Energy0.1%
  • Neuroscience0.1%
  • その他0.7%

トピック

  • Acute Myeloid Leukemia Research18.8%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment10.5%
  • Chronic Myeloid Leukemia Treatments3.5%
  • Cancer Genomics and Diagnostics3.3%
  • Hematopoietic Stem Cell Transplantation3.1%
  • RNA modifications and cancer3.1%
  • その他57.7%

共著者

全論文

検索で開く
  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard A. Larson, Michelle M. Le Beau, Mignon L. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte M. Niemeyer, Olatoyosi Odenike, Seishi Ogawa, Alberto Órfão, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching‐Hon Pui, Jerald P. Radich, Andreas Reiter, Marı́a Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt‐Graeff, Akiko Shimamura, Jorge Sierra, Wendy Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei‐Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi - Blood 2022 被引用: 2,693

  2. Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Akifumi Takaori‐Kondo, Takayuki Ishikawa, Shigeru Chiba, Senji Kasahara, Yasushi Miyazaki, Agnès Viale, Kety Huberman, Pierre Fenaux, Monika Beličková, Michael R. Savona, Virginia M. Klimek, Fábio Pires de Souza Santos, Jacqueline Boultwood, Ιoannis Kotsianidis, Valeria Santini, Françesc Solé, Uwe Platzbecker, Michael Heuser, Peter Valent, Kazuma Ohyashiki, Carlo Finelli, Maria Teresa Voso, Lee‐Yung Shih, Michaëla Fontenay, Joop H. Jansen, José Cervera, Norbert Gattermann, Benjamin L. Ebert, Rafael Bejar, Luca Malcovati, Mario Cazzola, Seishi Ogawa, Eva Hellström‐Lindberg, Elli Papaemmanuil - NEJM Evidence 2022 被引用: 813

  3. Revised International Prognostic Scoring System for Myelodysplastic Syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Teresa Vallespı́, Arjan A. van de Loosdrecht, Ulrich Germing, Detlef Haase - Blood 2012 被引用: 3,140

  4. Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis

    著者: , , , , , , , , , , , , , , , , , , - NEJM Evidence 2023 被引用: 295

  5. Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacqueline Boultwood, Fábio Pires de Souza Santos, Julie Schanz, Senji Kasahara, Takayuki Ishikawa, Hisashi Tsurumi, Akifumi Takaori‐Kondo, Toru Kiguchi, Chantana Polprasert, John M. Bennett, Virginia M. Klimek, Michael R. Savona, Monika Beličková, Christina Ganster, Laura Palomo, Guillermo Sanz, Lionel Adès, Matteo Giovanni Della Porta, Harold K. Elias, Alexandra Smith, Yesenia Werner, Minal Patel, Agnès Viale, Katelynd Vanness, Donna Neuberg, Kristen E. Stevenson, Kamal Menghrajani, Kelly L. Bolton, Pierre Fenaux, Andrea Pellagatti, Uwe Platzbecker, Michael Heuser, Peter Valent, Shigeru Chiba, Yasushi Miyazaki, Carlo Finelli, Maria Teresa Voso, Lee‐Yung Shih, Michaëla Fontenay, Joop H. Jansen, José Cervera, Yoshiko Atsuta, Norbert Gattermann, Benjamin L. Ebert, Rafael Bejar, Peter L. Greenberg, Mario Cazzola, Eva Hellström-Lindberg, Seishi Ogawa, Elli Papaemmanuil - Nature Medicine 2020 被引用: 636

  6. Clinical and biological implications of driver mutations in myelodysplastic syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anthony R. Green, Jacqueline Boultwood, Paresh Vyas, Eva Hellström‐Lindberg, David Bowen, Mario Cazzola, Michael R. Stratton, Peter J. Campbell - Blood 2013 被引用: 1,832

  7. SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , E. Joanna Baxter, J Score, Anna Gallì, Matteo Giovanni Della Porta, Erica Travaglino, Michael J. Groves, Sudhir Tauro, Nikhil C. Munshi, Kristina Anderson, Adel K. El‐Naggar, Andrej Fischer, Ville Mustonen, Alan J. Warren, Nicholas C.P. Cross, Anthony R. Green, P. Andrew Futreal, Michael R. Stratton, Peter J. Campbell - New England Journal of Medicine 2011 被引用: 1,216

  8. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Attilio Orazi, Elli Papaemmanuil, Andreas Reiter, David M. Ross, Michael R. Savona, Akiko Shimamura, Radek C. Skoda, Françesc Solé, Richard M. Stone, Ayalew Tefferi, Matthew J. Walter, David Wu, Benjamin L. Ebert, Mario Cazzola - Blood 2022 被引用: 208

  9. Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 被引用: 1,972

  10. SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Detlef Haase, Heinz Tüchler, Peter L. Greenberg, Seishi Ogawa, Eva Hellström‐Lindberg, Mario Cazzola - Blood 2020 被引用: 293

  11. Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome

    著者: , , , , , , , , , , , , , , , , , - Nature Cell Biology 2022 被引用: 130

  12. Multiparameter prediction of myeloid neoplasia risk

    著者: , , , , , , , , , , , , , - Nature Genetics 2023 被引用: 108

  13. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2017 被引用: 376

  14. Germ lineDDX41mutations define a unique subtype of myeloid neoplasms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shigeru Chiba, Hisashi Tsurumi, Senji Kasahara, Carsten Müller‐Tidow, Akifumi Takaori‐Kondo, Kazuma Ohyashiki, Toru Kiguchi, Fumihiko Matsuda, Joop H. Jansen, Chantana Polprasert, Piers Blombery, Yoichiro Kamatani, Satoru Miyano, Luca Malcovati, Torsten Haferlach, Michiaki Kubo, Mario Cazzola, Austin Kulasekararaj, Lucy A. Godley, Jaroslaw P. Maciejewski, Seishi Ogawa - Blood 2022 被引用: 143

  15. TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michaëla Fontenay, Olivier Kosmider, Michal Bar‐Natan, David P. Steensma, Richard M. Stone, Michael Heuser, Felicitas Thol, Mario Cazzola, Luca Malcovati, Aly Karsan, Christina Ganster, Eva Hellström‐Lindberg, Jacqueline Boultwood, Andrea Pellagatti, Valeria Santini, Lynn Quek, Paresh Vyas, Heinz Tüchler, Peter L. Greenberg, Rafael Bejar - Leukemia 2019 被引用: 259

  16. Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Phillip Scheinberg, Reinhard Stauder, Arjan A. van de Loosdrecht, Andrew H. Wei, Mikkael A. Sekeres, Pierre Fenaux - Blood 2023 被引用: 92

  17. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

    著者: , , , , , , , , , , , , , , , , , , , , , - Blood 2013 被引用: 667

  18. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , - Blood 2016 被引用: 361

  19. SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

    著者: , , , , , , , , , , , , , , , , , , , , , - Blood 2015 被引用: 428

  20. Clinical significance of somatic mutation in unexplained blood cytopenia

    著者: , , , , , , , , , , , , , , , , , , , , - Blood 2017 被引用: 469

  21. Relationship between clone metrics and clinical outcome in clonal cytopenia

    著者: , , , , , , , , , , , , , , , , , , , - Blood 2021 被引用: 103

  22. Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia

    著者: , , , , , , , , , , , , , , , , , - Nature Communications 2018 被引用: 184

  23. Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matteo Della Porta, Kety Huberman, Pierre Fenaux, Monika Beličková, Michael R. Savona, Virginia M. Klimek, Fábio Pires de Souza Santos, Jacqueline Boultwood, Ιoannis Kotsianidis, Valeria Santini, Françesc Solé, Uwe Platzbecker, Michael Heuser, Peter Valent, Carlo Finelli, Maria Teresa Voso, Lee‐Yung Shih, Seishi Ogawa, Michaëla Fontenay, Joop H. Jansen, José Cervera, Benjamin L. Ebert, Rafael Bejar, Peter L. Greenberg, Norbert Gattermann, Luca Malcovati, Mario Cazzola, David B. Beck, Eva Hellström‐Lindberg, Elli Papaemmanuil - Blood 2024 被引用: 49

  24. Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

    著者: , , , , , , , , , , , , , , , - Blood 2018 被引用: 178